IP Library Patent Application 13017768
Patent Application
App. No. 13/017,768

Nitric Oxide Delivery System

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
13/017,768
Abstract

Methods and systems of using liquid nitrogen dioxide (N 2 O 4 ) with a ventilator can generate and deliver nitric oxide to a patient by means of a ventilator.

Claims (44)

1 . A system for delivering a therapeutic amount of nitric oxide comprising:

a ventilator delivering a gas mixture of oxygen and/or air;

a liquid reservoir containing dinitrogen tetroxide;

a tube from the reservoir configured to connect to the gas supply being delivered to the patient;

a first receptacle coupled to the tube; wherein the receptacle comprises a surface-activated material saturated with an aqueous solution of an antioxidant and

a patient interface coupled to the first receptacle, wherein the first receptacle converts nitrogen dioxide into nitric oxide prior to reaching the patient interface.

2 . The system of claim 1 , wherein the source of air includes nitrogen, oxygen-enriched air, or substantially pure oxygen.

3 . The system of claim 1 , wherein the reservoir contains compressed nitrogen dioxide with or without a diluent gas.

4 . The system of claim 1 , wherein the receptacle comprises a cartridge.

5 . The system of claim 1 , wherein the surface-activated material is a silica gel, activated charcoal, activated carbon, activated alumina or calcium sulfate.

6 . The system of claim 1 , wherein the antioxidant is ascorbic acid, alpha tocopherol, or gamma tocopherol.

7 . The system of claim 1 , further comprising a second receptacle wherein the second receptacle comprises a surface-activated material saturated with an aqueous solution of an antioxidant.

8 . The system of claim 1 , wherein the patient interface is a mouth piece, face mask, or fully-sealed face mask, or the interface is a tracheal intubator.

9 . The system of claim 1 , further comprising a heating element associated with the reservoir.

10 . The system of claim 1 , further comprising a valve coupled to the reservoir and the tube.

11 . The system of claim 1 , further comprising a gas mixer in communication with the reservoir and the source of air.

12 . The system of claim 1 , wherein the tube has a bore size of about 25 microns or less.

13 . The system of claim 1 , wherein the tube has a bore size of 10 microns or less.

14 . A system for delivering a therapeutic amount of nitric oxide comprising:

a ventilator delivering a gas mixture of oxygen and/or air;

a gas bottle containing NO 2 in a diluent gas;

a flow regulator and a valve configured to be connected to the gas bottle;

a first receptacle; wherein the receptacle comprises a surface-activated material saturated with an aqueous solution of an antioxidant and

a patient interface coupled to the first receptacle, wherein the first receptacle converts nitrogen dioxide into nitric oxide prior to reaching the patient interface.

15 . The system of claim 14 , wherein the gas bottle contains 800 to 2000 ppm of NO 2 .

16 . The system of claim 14 , wherein the receptacle comprises a cartridge.

17 . The system of claim 14 , wherein the surface-activated material is a silica gel, activated charcoal, activated carbon, activated alumina or calcium sulfate.

18 . The system of claim 14 , wherein the antioxidant is ascorbic acid, alpha tocopherol, or gamma tocopherol.

19 . The system of claim 14 , further comprising a second receptacle wherein the second receptacle comprises a surface-activated material saturated with an aqueous solution of an antioxidant.

20 . The system of claim 14 , wherein the patient interface is a mouth piece, face mask, or fully-sealed face mask, or the patient interface is a tracheal intubator.

21 . A method of providing a therapeutic amount of nitric oxide to a mammal comprising:

injecting nitrogen dioxide into the air/oxygen gas stream leaving the ventilator;

exposing the nitrogen dioxide to a surface-active material coated with an antioxidant to convert the gaseous nitrogen dioxide to nitric oxide at ambient temperature; and

transporting the nitric oxide in a therapeutic amount to a mammal.

22 . The method of claim 21 , wherein the nitrogen dioxide is generated from liquid nitrogen dioxide contained within a reservoir.

23 . The method of claim 21 , wherein the reservoir is coupled to a tube wherein tube has a bore size of about 25 microns or less.

24 . The method of claim 22 , further comprising a valve coupled to the reservoir and the tube.

25 . The method of claim 21 , wherein injecting nitrogen dioxide into the air/oxygen gas stream includes providing a predetermined dose of nitrogen dioxide at a particular temperature.

26 . The method of claim 21 , further comprising predetermining the concentration of nitrogen dioxide in the air/oxygen gas stream by controlling the flow rate of the air/oxygen gas stream.

27 . The method of claim 21 , further comprising mixing nitrogen dioxide and the air/oxygen gas before exposing the nitrogen dioxide to a surface-active material.

28 . The method of claim 21 , wherein the surface-activated material is a silica gel, activated charcoal, activated carbon, activated alumina or calcium sulfate.

29 . The method of claim 21 , wherein the antioxidant is ascorbic acid, alpha tocopherol, or gamma tocopherol.

30 . The method of claim 21 , further comprising contacting the nitric oxide with a second surface-active material coated with an antioxidant immediately prior to inhalation by the mammal.

31 . The method of claim 21 , wherein the nitrogen dioxide is introduced from a pressurized gas bottle containing nitrogen dioxide in a diluent gas.

Assignments (5)
TERMINATION AND RELEASE OF INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Jan 3, 2024
From: RUNWAY GROWTH FINANCE CORP (F/K/A RUNWAY GROWTH CREDIT FUND INC.)
To: VERO BIOTECH INC. (F/K/A VERO BIOTECH LLC)
Reel/Frame 066186/0611 →
CHANGE OF NAME Recorded Feb 14, 2022
From: VERO BIOTECH LLC
To: VERO BIOTECH INC.
Reel/Frame 059085/0418 →
SECURITY INTEREST Recorded Dec 29, 2020
From: VERO BIOTECH LLC
To: RUNWAY GROWTH CREDIT FUND INC.
Reel/Frame 054866/0589 →
CHANGE OF NAME Recorded Sep 25, 2020
From: GENO LLC
To: VERO BIOTECH LLC
Reel/Frame 053891/0628 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 21, 2011
From: FINE, DAVID H.; DENTON, RYAN; VASQUEZ, GREGORY; JOHNSON, BRYAN
To: GENO LLC
Reel/Frame 026473/0360 →